Evaluation of calprotectin and ischemia-modified albumin serum levels as biomarkers to measure disease activity in Behçet’s disease

Abstract Background Although several cytokines and markers have been recognized to assess disease activity in Behçet’s disease (BD), they are not routinely utilized in daily practice. This study aimed at assessing the usefulness of calprotectin and ischemia-modified albumin (IMA) serum concentration...

Full description

Bibliographic Details
Main Authors: Yasmin Adel, Yousra Sadeq, Shereen A. Machaly
Format: Article
Language:English
Published: SpringerOpen 2023-10-01
Series:Egyptian Rheumatology and Rehabilitation
Subjects:
Online Access:https://doi.org/10.1186/s43166-023-00208-7